Trial Profile
Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2021
Price :
$35
*
At a glance
- Drugs Gliclazide (Primary) ; Perindopril/indapamide (Primary) ; Antihyperglycaemics
- Indications Cardiovascular disorders; Diabetic angiopathies; Diabetic complications; Diabetic retinopathy; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ADVANCE-ON
- 13 Jul 2019 Results of post hoc analysis assessing benefits of using eGFR slopes for prediction of major clinical outcomes in diabetes using data from ADVANCE and ADVANCE-ON trials published in the Diabetologia
- 09 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jan 2014 United Kingdom Clinical Research Network reports planned end date as 1 April 2014.